Ascendis Pharma AS (ASND)
124.27
-1.76
(-1.40%)
USD |
NASDAQ |
Nov 14, 16:00
118.46
-5.81
(-4.68%)
After-Hours: 20:00
Ascendis Pharma Gross Profit (Annual): 240.69M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 240.69M |
| December 31, 2022 | 41.17M |
| December 31, 2021 | 5.034M |
| Date | Value |
|---|---|
| December 31, 2020 | 7.940M |
| December 31, 2019 | 14.97M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
5.034M
Minimum
2021
240.69M
Maximum
2023
61.96M
Average
14.97M
Median
2019
Gross Profit (Annual) Benchmarks
| Novo Nordisk AS | 28.53B |
| Evaxion Biotech AS | -- |
| Biodexa Pharmaceuticals PLC | -4.587M |
| NuCana PLC | -- |
| Genfit SA | 30.56M |